ISN Journal summaries: effect of pravastatin on ADPKD and 10 years of Kidney International Reports®
Kidney International® A randomized controlled trial evaluated the effect of pravastatin on kidney disease outcomes in adult patients with early-stage autosomal dominant polycystic kidney disease This randomized, double-blind trial evaluated whether pravastatin could slow disease progression in adults with early autosomal dominant polycystic kidney disease (ADPKD) and preserved kidney function. Researchers followed 150 participants receiving pravastatin or a placebo...